[Systemic treatment of common warts with beta-interferon].
A 21-year-old female suffering from recalcitrant subungual and periungual common warts was treated without success for 3 years by both conservative and surgical approaches. After intravenous therapy with human fibroblast beta interferon (IFN-beta; 3 cycles, 14 days each; daily dose 1-3 x 10(6) IU) complete remission of all warts was achieved. Even 1 year after the treatment with human IFN-beta, the patient was still free of warts. We conclude that in selected cases common warts can be treated with intravenous human fibroblast IFN-beta. However, because of the high cost of this well-tolerated therapy, it cannot be recommended for all patients with common warts.